CD68 and neoplasm: Additionally, a high density of CD163+ macrophage was correlated with higher PD-L1 expression in tumor cells and poor clinical outcomes such as advanced FIGO stages and shorter recurrence-free survival; but the same effect was not observed in CD68+ macrophages [48,66].